Robert W. Malone

From Infogalactic: the planetary knowledge core
Jump to: navigation, search

<templatestyles src="Module:Hatnote/styles.css"></templatestyles>

Not to be confused with Robert Malone.
Robert Wallace Malone
Citizenship United States
Education MD, Northwestern University
B.S., University of California Davis
Occupation Virologist
Website rwmalonemd.com

Robert Wallace Malone is an American virologist and immunologist. His work has focused on mRNA technology, pharmaceuticals, and drug repurposing research. During the COVID-19 pandemic, he has been criticized by the mainstream media for allegedly promoting misinformation.

Early life and education

Robert Malone graduated from the University of California Davis, and received his MD from Northwestern University.[1]

Career

In the 1980s, while a researcher at the Salk Institute, Malone conducted studies on messenger ribonucleic acid (mRNA) technology, discovering that it was possible to transfer mRNA protected by a liposome into cultured cells to signal the information needed for the production of proteins.[2][3] In the early 1990s, he collaborated with Jon A. Wolff, Dennis A. Carson, and others on a study that first suggested the possibility of synthesizing mRNA in a laboratory to trigger the production of a desired protein.[4]

Until 2020, Malone was chief medical officer at Alchem Laboratories, a Florida pharmaceutical company.[5] He was previously director of clinical affairs for Avancer Group, a member of the scientific advisory board of EpiVax, assistant professor at the University of Maryland Baltimore school of medicine, and an adjunct associate professor of biotechnology at Kennesaw State University.[6] In 2016, Atheric Pharmaceuticals was contracted by the United States Government to assist in the development of a treatment for the Zika virus by evaluating the efficacy of existing drugs.[7][8]

Malone claims to be the inventor of mRNA vaccines, although credit for the distinction is more often given by mainstream sources to later advancements by Katalin Karikó or Derrick Rossi.[9][2][10][11]

COVID-19

In early 2020, during the COVID-19 pandemic, Malone was involved in research into the heartburn medicine famotidine (Pepcid) as a potential COVID-19 treatment following anecdotal evidence suggesting that it may have been associated with higher COVID-19 survival. Malone, then with Alchem Laboratories, suspected famotidine may target an enzyme that the virus (SARS-COV-2) uses to reproduce, and recruited a computational chemist to help design a 3D-model of the enzyme based on the viral sequence and comparisons to the 2003 SARS virus.[12][13] After encouraging preliminary results, Alchem Laboratories, in conjunction with New York's Northwell Health, initiated a clinical trial on famotidine and hydroxychloroquine.[12] Malone resigned from Alchem shortly after the trial began and Northwell paused the trial due to a shortage of hospitalized patients.[5][14]

Malone received criticism from mainstream sources for propagating alleged COVID-19 misinformation, including making claims about the toxicity of spike proteins generated by some COVID-19 vaccines, and tweeting a study by others questioning vaccine safety that was later retracted. He said LinkedIn suspended his account over what he claimed were posts he had made questioning the efficacy of some COVID-19 vaccines.[3][11][15][16]

With another researcher, Malone successfully proposed to the publishers of Frontiers in Pharmacology a special issue featuring early observational studies on existing medication used in the treatment of COVID-19, for which they recruited other guest editors, contributors, and reviewers. Malone and most other guest editors resigned in April 2021, when the journal rejected two of the papers selected: one on famotidine co-authored by Malone and another submitted by physician Pierre Kory on the use of ivermectin.[14]

Selected publications

  • Lua error in package.lua at line 80: module 'strict' not found.
  • Lua error in package.lua at line 80: module 'strict' not found.
  • Lua error in package.lua at line 80: module 'strict' not found.
  • Lua error in package.lua at line 80: module 'strict' not found.
  • Lua error in package.lua at line 80: module 'strict' not found.
  • Lua error in package.lua at line 80: module 'strict' not found.
  • Lua error in package.lua at line 80: module 'strict' not found.
  • Lua error in package.lua at line 80: module 'strict' not found.
  • Lua error in package.lua at line 80: module 'strict' not found.
  • Lua error in package.lua at line 80: module 'strict' not found.

References

  1. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  2. ↑ 2.0 2.1 Lua error in package.lua at line 80: module 'strict' not found.
  3. ↑ 3.0 3.1 Lua error in package.lua at line 80: module 'strict' not found.
  4. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  5. ↑ 5.0 5.1 Lua error in package.lua at line 80: module 'strict' not found.
  6. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  7. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  8. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  9. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  10. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  11. ↑ 11.0 11.1 Lua error in package.lua at line 80: module 'strict' not found.
  12. ↑ 12.0 12.1 Lua error in package.lua at line 80: module 'strict' not found.
  13. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  14. ↑ 14.0 14.1 Lua error in package.lua at line 80: module 'strict' not found.
  15. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  16. ↑ Lua error in package.lua at line 80: module 'strict' not found.

External links

Lua error in package.lua at line 80: module 'strict' not found.

Retrieved from "https://infogalactic.com/w/index.php?title=Robert_W._Malone&oldid=726307330"